EPO and chronic kidney disease: The molecular mechanisms associating chronic inflammation with anisocytosis have been hypothesized among diabetic and chronic kidney disease patients including a decrease in erythrocyte lifespan, suppression in erythropoietin response, and impairment in iron metabolism.18, 19